000 01497 a2200445 4500
005 20250516104840.0
264 0 _c20130702
008 201307s 0 0 eng d
022 _a1463-1326
024 7 _a10.1111/j.1463-1326.2012.01691.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTkáč, I
245 0 0 _aPharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.
_h[electronic resource]
260 _bDiabetes, obesity & metabolism
_cFeb 2013
300 _a189-91 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAlleles
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aMale
650 0 4 _aMetformin
_xpharmacology
650 0 4 _aMiddle Aged
650 0 4 _aOrganic Cation Transport Proteins
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aTreatment Outcome
700 1 _aKlimčáková, L
700 1 _aJavorský, M
700 1 _aFabianová, M
700 1 _aSchroner, Z
700 1 _aHermanová, H
700 1 _aBabjaková, E
700 1 _aTkáčová, R
773 0 _tDiabetes, obesity & metabolism
_gvol. 15
_gno. 2
_gp. 189-91
856 4 0 _uhttps://doi.org/10.1111/j.1463-1326.2012.01691.x
_zAvailable from publisher's website
999 _c22015893
_d22015893